Alexander Wilson
The Yankees got the sentence everyone wanted from Carlos Rodon. His UCL is intact.
That does not make the injury nothing. Rodon is dealing with heavy inflammation in his left elbow, and the Yankees placed him on the 15-day injured list Friday. For a starter who already had offseason elbow surgery and was supposed to pitch Saturday, this still lands with a thud.
Carlos Rodon said he hopes this is not a long recovery process, which is about as much comfort as the Yankees can take right now. The ligament news keeps the worst fear off the table for the moment. The inflammation keeps the rotation problem very much alive.
Yankees avoided the nightmare version
Rodon has been useful when available this season. Through nine starts, he owns a 3.30 ERA across 46.1 innings with 52 strikeouts, 26 walks, and a .195 opponent average. The walk total has been messy, but hitters still have trouble squaring him up.
The injury still stings even after the initial scan brought some relief. The Yankees are not losing a back-end placeholder. They are losing a lefty who can still overpower hitters, cover real innings, and give them a different look in a rotation that has already been forced to patch around health issues.
There is also the timing. The Yankees are trying to stop the season from getting weird in July, and every rotation gap makes that harder. One skipped turn can be handled. Multiple weeks without Rodon, especially with Max Fried also working through an elbow issue, changes the way the club has to manage every game.
Yankees still have a rotation squeeze
The Yankees can move pieces around for a start or two. Ryan Yarbrough and Paul Blackburn are the types of arms who can cover a spot if needed, and Triple-A Scranton/Wilkes-Barre is there for an emergency. None of that feels like a real replacement for Rodon if this absence stretches.
This is where the deadline pressure gets real. The Yankees already had offensive concerns, bullpen questions, and a long injury list. Now the rotation gets dragged back into the room too. If Rodon is back after the minimum stay, fine, the club can exhale a bit. If the inflammation lingers, Brian Cashman may have another problem to shop for.
The intact UCL is the headline because it matters. No one should pretend otherwise. But the Yankees still need the swelling down, the arm responding, and Rodon back on a mound before this becomes good news instead of less-bad news.
More about:New York Yankees
